Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01753713
Title Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|National Cancer Institute (NCI)|Novartis
Indications

brain cancer

glioblastoma

gliosarcoma

Therapies

Dovitinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.